Research note · 14 September 2026
Agilysys Inc AGYS
SHORT price $109.07 · base case $85.51 · expected +32% over 540 days
The call
AGYS is overvalued as the current price of $109.07 embeds a 71.76x trailing P/E that assumes sustained hypergrowth and structural margin expansion, despite the company's TTM FCFF margin of 24.4% being artificially elevated by a temporary capex cycle low. Reversion to the lower half of AGYS's own five-year P/E range (26.6x–221.6x), normalization of capital spending, and inherent cyclicality in hospitality IT budgets imply a fair value well below the current market price.
Why the opportunity exists, in the desk's view: a narrative overshoot.
What decides the case
- Subscription revenue growth trajectory
- Capex intensity normalization
- AI infrastructure and compliance costs
What breaks the case
| Shock to the base case | Value per share | vs price |
|---|---|---|
| Base case as planned | $85.51 | -22% |
| Starting cash flow 10% higher | $93.65 | -14% |
| Growth 5 points higher every year | $102.83 | -6% |
| Discount rate 100bp higher | $74.12 | -32% |
| Starting cash flow 10% lower | $77.37 | -29% |
| Growth 5 points lower every year | $70.80 | -35% |
The base case equals the price at a 7.6% discount rate, or if every year's growth were +6.6% points different. Thresholds, not forecasts.
Model-authored research with an editorial gate; every figure traces to the filing or a stated assumption and every calculation was reproduced before publication. Not investment advice. Do not redistribute.